Tarsus Pharmaceuticals, Inc.
TARS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001819790
In the last 90 days, Tarsus Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 6 sales; 256 institutions reported holding it in 13F filings for Q2 2026, worth $2.98B in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Tarsus Pharmaceuticals, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- −1 vs. Q3 2021
- Shares held
- 13.1M
- +203.5K (+1.6%) vs. Q3 2021
- Total value
- $294.2M
- +$16.9M (+6.1%) vs. Q3 2021
- New holders
- 2
- 17 more added
- Sold out
- 3
- 8 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TARS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 256 | $2.98B |
| Q1 2026 | 253 | $3.17B |
| Q4 2025 | 246 | $3.61B |
| Q3 2025 | 220 | $2.67B |
| Q2 2025 | 205 | $1.87B |
| Q1 2025 | 195 | $2.26B |
| Q4 2024 | 195 | $2.23B |
| Q3 2024 | 162 | $1.43B |
| Q2 2024 | 148 | $1.09B |
| Q1 2024 | 157 | $1.43B |
| Q4 2023 | 116 | $652.0M |
| Q3 2023 | 105 | $529.4M |
| Q2 2023 | 92 | $387.3M |
| Q1 2023 | 74 | $252.1M |
| Q4 2022 | 69 | $301.0M |
| Q3 2022 | 75 | $350.8M |
| Q2 2022 | 73 | $291.7M |
| Q1 2022 | 51 | $222.2M |
| Q4 2021 | 43 | $294.2M |
| Q3 2021 | 44 | $277.4M |
| Q2 2021 | 44 | $378.5M |
| Q1 2021 | 41 | $410.4M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Tarsus Pharmaceuticals, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tucker Asset Management LLC | 4 | $96 | 0.00% | 00.0% | Unchanged |
| American Portfolios Advisors | 39 | $878 | 0.00% | 00.0% | Unchanged |
| Spire Wealth Management | 100 | $2.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 200 | $5.00K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 515 | $12.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 652 | $14.0K | 0.00% | +187+40.2% | Added |
| Legal & General Group Plc | 818 | $19.0K | 0.00% | 00.0% | Unchanged |
| STRS Ohio | 2,100 | $47.0K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 2,145 | $48.0K | 0.00% | +1,183+123.0% | Added |
| Royal Bank of Canada | 2,147 | $49.0K | 0.00% | +1,222+132.1% | Added |
| UBS Group AG | 3,084 | $70.0K | 0.00% | +2,584+516.8% | Added |
| American International Group, Inc. | 4,480 | $101.0K | 0.00% | −134−2.9% | Reduced |
| California State Teachers Retirement System | 4,640 | $104.0K | 0.00% | +120+2.7% | Added |
| Deutsche Bank AG | 5,687 | $128.0K | 0.00% | +270+5.0% | Added |
| New York State Common Retirement Fund | 5,872 | $132.0K | 0.00% | −9−0.2% | Reduced |
| Wells Fargo & Company | 7,654 | $172.0K | 0.00% | −2,130−21.8% | Reduced |
| Dimensional Fund Advisors LP | 8,990 | $202.0K | 0.00% | +8,990 | New |
| Bank of America Corp | 10,662 | $240.0K | 0.00% | +4,891+84.8% | Added |
| Morgan Stanley | 11,238 | $253.0K | 0.00% | −17,292−60.6% | Reduced |
| Allspring Global Investments Holdings, LLC | 12,885 | $289.0K | 0.00% | +12,885 | New |
| Invesco Ltd. | 23,904 | $538.0K | 0.00% | −4,710−16.5% | Reduced |
| Nuveen Asset Management, LLC | 21,763 | $565.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 25,286 | $569.0K | 0.00% | +763+3.1% | Added |
| Goldman Sachs Group Inc | 28,103 | $632.0K | 0.00% | +1,623+6.1% | Added |
| SG Americas Securities, LLC | 44,330 | $997.0K | 0.01% | −1,923−4.2% | Reduced |
| Charles Schwab Investment Management Inc | 47,181 | $1.06M | 0.00% | +415+0.9% | Added |
| Northern Trust Corp | 71,781 | $1.61M | 0.00% | −2,230−3.0% | Reduced |
| Geode Capital Management, LLC | 125,815 | $2.83M | 0.00% | +2,117+1.7% | Added |
| State Street Corp | 129,742 | $2.92M | 0.00% | +2,940+2.3% | Added |
| Ghost Tree Capital, LLC | 170,000 | $3.83M | 1.46% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 174,736 | $3.93M | 0.00% | +171,499+5,298.1% | Added |
| Ensign Peak Advisors, Inc | 242,451 | $5.46M | 0.01% | +42,451+21.2% | Added |
| Sands Capital Ventures, LLC | 260,000 | $5.85M | 0.87% | 00.0% | Unchanged |
| Jefferies Group LLC | 422,993 | $9.52M | 0.18% | 00.0% | Unchanged |
| BlackRock Inc. | 448,958 | $10.1M | 0.00% | +7,338+1.7% | Added |
| Vanguard Group Inc | 459,190 | $10.3M | 0.00% | +30,200+7.0% | Added |
| Cowen and Company, LLC | 514,289 | $11.6M | 1.10% | 00.0% | Unchanged |
| TimesSquare Capital Management, LLC | 660,800 | $14.9M | 0.13% | +10,020+1.5% | Added |
| Perceptive Advisors LLC | 1,296,416 | $29.2M | 0.45% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 1,403,331 | $31.6M | 1.88% | −41,500−2.9% | Reduced |
| Frazier Management LLC | 1,417,157 | $31.9M | 2.45% | 00.0% | Unchanged |
| RTW Investments, LP | 2,013,601 | $45.3M | 0.66% | 00.0% | Unchanged |
| Vivo Capital, LLC | 2,987,331 | $67.2M | 4.05% | 00.0% | Unchanged |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −22,198−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −6,008−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −44−100.0% | Sold out |